medigraphic.com
ISSN 2307-2113 (Electronic)
Revista Cubana de Información en Ciencias de la Salud (ACIMED)

2013, Number 4

<< Back Next >>

Revista Cubana de Información en Ciencias de la Salud (ACIMED) 2013; 24 (4)

Research fronts on vitiligo, a Scopus based bibliometric survey

Vega ARL, Arencibia JR

Language: English
References: 76
Page: 402-415
PDF size: 309.32 Kb.


ABSTRACT

Bibliometrics is frequently used to analyze the structural evolution of research fields, especially in biomedical areas. The present paper provides a macrostructure for scientific research on vitiligo conducted in the last fifty years using bibliometric methods. The data were retrieved from Scopus. A total 6 109 papers related to vitiligo were processed. An analysis was conducted of specialized terms based on the structure of the Medical Subject Headings (MeSH) thesaurus of the US National Library of Medicine. A structural approach was developed using term co-occurrence analysis. Hierarchical cluster analysis was used to identify the macrostructure, applying the CONCOR (CONvergence of iterated CORrelations) algorithm. Global scientific production on vitiligo was found to have increased exponentially in the last fifty years. Structural analysis revealed eight research areas divided in two blocks. On the one hand, an experimental block comprising studies on vitiligo, its relationships with cancer and other autoimmune diseases, its pathophysiology and pathogenesis; and on the other, a block including clinical studies covering various therapeutic approaches as well as the incidence and prevalence of the disease. The methodology applied constitutes a valid tool for the description and classification of biomedical knowledge domains. It also makes it possible to obtain a macrostructure which may be validated through bibliographic reviews.


REFERENCES

  1. Cavaller V. Datametrics? About the architecture of the metric disciplines. In: H. Kretschmer& F. Havemann (Eds.): Proceedings of WIS 2008, Fourth International Conference on Webometrics, Informetrics and Scientometrics & Ninth COLLNET Meeting. Berlin: Humboldt-Universitätzu Berlin, Institute for Library and Information Science (IBI); 2008.

  2. Borner K, Chen CM, Boyack KW. Visualizing knowledge domains. Annu Rev Inform Sci Technol. 2003;37:179-255.

  3. Glenisson P, Glanzel W, Janssens F, De Moor B. Combining full text and bibliometric information in mapping scientific disciplines. Inf Process Manage. 2005;41:1548-72.

  4. Morris SA, Van der Veer Martens B. Mapping research specialties. Annual Review of Information Science and Technology. 2008;42:213-95.

  5. Arencibia Jorge R, Vega Almeida RL, Marti Lahera Y. Domain analysis for the construction of a conceptual structure: A case study. Libres [Internet]. 2007 [cited 20 July 2013]. Available from: http://libres.curtin.edu.au/libres17n2/Arencibia-Jorge_Domain_Analysis.pdf/

  6. Chiu WT, Ho YS. Bibliometric analysis of homeopathy research during the period of 1991 to 2003. Scientometrics. 2005;63:3-23.

  7. Keiser J, Utzinger J. Trends in the core literature on tropical medicine: A bibliometric analysis from 1952-2002. Scientometrics. 2005;62:351-65.

  8. Lin CT, Chiang CT. Evaluating the performance of sponsored Chinese herbal medicine research. Scientometrics. 2007;70:67-84.

  9. Ramlogan R, Mina A, Tampubolon G, Metcalfe JS. Networks of knowledge: The distributed nature of medical innovation. Scientometrics. 2007;70:459-89.

  10. Riikonen P, Vihinen M. National research contributions: A case study on Finnish biomedical research. Scientometrics. 2008;77:207-22.

  11. Tsay MY, Chen YL. Journals of general & internal medicine and surgery: An analysis and comparison of citation. Scientometrics. 2005;64:17-30.

  12. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published work. J Dermatol. 2011;38:419-31.

  13. Halder RM, Chappell JL. Vitiligo Update. Seminars in Cutaneous Medicine and Surgery. 2009;28:86-92.

  14. Lotti T, Berti S, Moretti S. Vitiligo therapy. Expert Opinion on Pharmacotherapy. 2009;10:2779-85.

  15. Naldi L, Sassi F. Vitiligo. New Engl J Med. 2009;360:1788.

  16. Paterson E. Vitiligo. Journal of Visual Communication in Medicine. 2010;33:166-8.

  17. Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clinic ExperimDermatol. 2010;35:736-9.

  18. Viles J, Monte D, Gawkrodger DJ. A patient's journey: Vitiligo. BMJ. 2010;341:938-9.

  19. Belinchon I, Ramos JM, Sánchez-Yus E, Betlloch I. Dermatological scientific production from European Union authors (1987-2000). Scientometrics. 2004;61:271-81.

  20. Firoozabadi MR, Firooz A, Gorouhi F, Dowlati Y. Iran's contribution to the dermatology literature [1]. Internat J Dermatol. 2007;46:659-60.

  21. Stegmann J, Grohmann G. Citation rates, knowledge export and international visibility of dermatology journals listed and not listed in the Journal Citation Reports. Scientometrics. 2001;50:483-502.

  22. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick's Dermatology in General Medicine. Vol. I. EE.UU.: Mac Graw Hill. 2007:616-21.

  23. de Moya-Anegón F, Chinchilla-Rodríguez Z, Vargas-Quesada B, Corera-Álvarez, E, Muñoz-Fernández FJ, González-Molina A, et al. Coverage analysis of Scopus: a journal metric approach. Scientometrics. 2007;73:53-78.

  24. Callon M, Courtial JP, Turner WA, Bauin S. From translations to problematic networks: an introduction to co-word analysis. SocSci Inform. 1983;22:191-235.

  25. Jacobs N. Co-term network analysis as a means of describing the information landscapes of knowledge communities across sectors. J Docum. 2002;58:548-62.

  26. Stegmann J, Grohmann G. Hypothesis generation guided by co-word clustering. Scientometrics. 2003;56:111-35.

  27. Whittaker J. Creativity and conformity in science: Titles, keywords and co-word analysis. Soc Stud Sci. 1989;19:473-96.

  28. Zhang J, Wolfram D, Wang PL, Hong Y, Gillis R. Visualization of health-subject analysis based on query term co-occurrences. J Am SocInfSci Technol. 2008;59:1933-47.

  29. Borgatti SP, Everett MG, Freeman LC. Ucinet for Windows: software for social network analysis. Harvard, MA, EE.UU.: Analytic Technologies. 2002.

  30. Breiger RL, Boorman SA, Arabie P. An algorithm for clustering relational data with applications to social network analysis and comparison with multidimensional scaling. J MathemPsychol. 1975;12:328-82.

  31. Ferrari HR, Catanesi I. Aplicación del algoritmo CONCOR para la interpretación de estereotipos de comportamiento. MastozoolNeotrop. 1998;5:117-21.

  32. Magnusson MG, Mascia D. Knowledge creation and appropriation in biotech R&D: The role of formal and informal organizational structures. Göteborg: Chalmers workshop "Innovations and Entrepreneurship in Biotech/Pharmaceuticals and IT/Telecom. 2003.

  33. Pearl MC, Schulman SR. Techniques for the analysis of social structure in animal societies. Advances in the Study of Behavior. 1983;13:107-46.

  34. Sallán-Leyes JM. Influencia del trabajo en equipo en el desarrollo y aplicación de conocimiento: el papel de las redes sociales, IX Congreso de Ingeniería de Organización. Gijón; 2005.

  35. Vargas-Quesada B. Visualización y Análisis de Dominios Científicos mediante redes pathfinder (PFNET). Granada: Universidad de Granada. Doctoral Dissertation. 2005.

  36. Vega-Almeida RL. Ciencia de la Información y paradigma social. Granada: Universidad de Granada. Doctoral Dissertation. 2010.

  37. Csigó P, Vedres B. The Discourse of Consolidation in Hungary: An Empirical Study of the Discursive Field in Economic Policy - a Network Analysis Approach. Spain: 5th European International Conference on Social Networks; 1998.

  38. Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. EE.UU.: Proceedings of the National Academy of Sciences of the United States of America. 2003;100:872-7.

  39. Dudley ME, Wunderlich JR, Yang JC, Sherry RM, Topalian SL, Restifo NP, et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clinic Oncol. 2005;23:2346-57.

  40. Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, Rolland A, et al. Immune and clinical responses in patients with metastatic melanoma to CD34+ progenitor-derived dendritic cell vaccine. Canc Res. 2001;61:6451-8.

  41. Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D, et al. Prognostic significance of autoimmunity during treatment of melanoma with interferon. N Eng J Med. 2006;354:709-18.

  42. Overwijk WW, Lee DS, Surman DR, Irvine KR, Touloukian CE, Chan CC, et al. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:2982-7.

  43. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, De Jong LA, Vyth-Dreese FA, et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Experim Med. 2003;198:569-80.

  44. Rosenberg SA, White DE. Vitiligo in patients with melanoma: Normal tissue antigens can be targets for cancer immunotherapy. J Immunother. 1996;19:81-4.

  45. Van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Experim Med. 1999;190:355-66.

  46. Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo. J Experim Med. 2000;192:1637-43.

  47. Bor S, Feiwel M, Chanarin I. Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Brit J Dermatol. 1969;81:83-8.

  48. Brostoff J. Autoantibodies in patients with vitiligo. Lancet. 1969;2(7613):177-8.

  49. Cunliffe WJ, Hall R, Newell DJ. Stevenson CJ. Vitiligo, thyroid disease and autoimmunity. Brit J Dermatol. 1968:80:135-9.

  50. Mackay IR. Autoimmune aspects of three skin diseases: pemphigus, cutaneous lupus erythematosus and vitiligo. Austr J Dermatol. 1967;9:113-21.

  51. Nordberg J, Arner ESJ. Reactive oxygen species, antioxidants and the mammalian thioredoxin system. Free Rad Biol Med. 2001;31:1287-312.

  52. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 1993;74:395-404.

  53. Le Poole IC, Van den Wijngaard RMJGJ, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol. 1996;148:1219-28.

  54. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, et al. New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigm Cell Res. 2002;15:87-92.

  55. Njoo MD, Westerhof W. Vitiligo: Pathogenesis and treatment. Am J ClinDermatol. 2001;2:167-81.

  56. Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigm Cell Res. 2003;16:90-100.

  57. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Brit J Dermatol. 2001;145:476-9.

  58. Koga M. Vitiligo: A new classification and therapy. Brit J Dermatol. 1977;97:255-61.

  59. Parrish JA, Fitzpatrick TB, Shea C, Pathak MA. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high intensity long wave ultraviolet light system. Arch Dermatol. 1976;112:1531-4.

  60. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology. 1998;197:167-70.

  61. Kovacs SO. Vitiligo. J Am AcadDermatol. 1998;38:647-66.

  62. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. ToxicolApplPharmacol. 2004;195:298-308.

  63. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo: Meta-analysis of the literature. Arch Dermatol. 1998;134:1532-40.

  64. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am AcadDermatol. 2000;42(2 I):245-53.

  65. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. 1994;7:193-203.

  66. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am AcadDermatol. 2001;44:999-1003.

  67. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UV-A. Arch Dermatol. 1997;133(12):1525.

  68. Halder RM, Grimes PE, Cowan CA. Childhood vitiligo. J Am AcadDermatol. 1987;16:948-54.

  69. Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J Dermatol. 1999: 26:653-7.

  70. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Álvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1 % tacrolimus vs 0.05 % clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581-5.

  71. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: A case study on 33 patients. Dermatology. 1995;190:223-9.

  72. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. ClinImmunolImmunopathol. 1997;84:223-43.

  73. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. PigmCell Res. 2003;16:208-14.

  74. Schneider JW, Borlund P. Introduction to bibliometrics for construction and maintenance of thesauri: methodical considerations. Journal of Documentation. 2004;60(5):524-49.

  75. Hearst MA. The use of categories and clusters for organizing retrieval results. In: T. Strzalkowsky (Ed.): Natural language information retrieval. Netherlands: Springer, 1999:333-74.

  76. Han J, Kamber M. Datamining: Concepts an techniques. Burlington: Morgan Kaufmann Publishers, 2000.




2020     |     www.medigraphic.com